Page 3 - Flipbook
P. 3

Disclosures











                    • Institutional research funds: Bavarian Nordic; Bristol-Myers Squibb;

                       Clovis Oncology; Debiopharm; Immunomedics; Pfizer; Merck; QED

                       Therapeutics; GlaxoSmithKline; MiratiTherapeutics; Kure It Cancer

                       Research








                    • Consulting: AstraZeneca; DyaniaHealth; EMD Serono;

                       Immunomedics; Infinity Pharmaceuticals; Janssen; Merck;

                       MiratiTherapeutics; Genentech; Pfizer; Seattle Genetics
   1   2   3   4   5   6   7   8